Pacific Biosciences Of California PACB
NASDAQ PACB
$1.27 +0.00 (+0.00%)
At close: Aug 20, 2026 · 2:23 PM UTC

Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026)

Pacific Biosciences Of California (PACB) posted quarterly Amortization - Intangibles of $183000.0 for Q1 2026, down 99.95% year-over-year from $362.0 million in Q1 2025, and down 78.03% quarter-over-quarter from $833000.0 in Q4 2025.

Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026) Analysis & Trends

Pacific Biosciences Of California's Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $183000.0 for Q1 2026.

  • In Q1 2026, Amortization - Intangibles fell 99.95% year-over-year to $183000.0; the TTM figure through Mar 2026 stood at $2.0 million (down 99.44% YoY), while the FY2025 annual figure was $364.5 million, up 3780.99% from the prior year.
  • Amortization - Intangibles for Q1 2026 stood at $183000.0, down from $833000.0 in the prior quarter.
  • The five-year high for Amortization - Intangibles was $362.0 million in Q1 2025, with the low at -$4.0 million in Q4 2024.
  • The 5-year median for Amortization - Intangibles is $787000.0 (2023), against an average of $26.8 million.
  • The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles sank 173.56% in 2024, then soared 26857.71% in 2025.
  • Pacific Biosciences Of California's Amortization - Intangibles stood at $183000.0 in 2022, then soared by 2859.56% to $5.4 million in 2023, then tumbled by 173.56% to -$4.0 million in 2024, then surged by 120.91% to $833000.0 in 2025, then slumped by 78.03% to $183000.0 in 2026.
  • Business Quant data shows PACB's Amortization - Intangibles at $183000.0 in Q1 2026, $833000.0 in Q4 2025, and $833000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn
10 Pacific Biosciences Of California 394.84 Mn 157.97 Mn 12.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 833,000.00
Mar 31, 2026 183,000.00
Dec 31, 2025 833,000.00
Sep 30, 2025 833,000.00
Jun 30, 2025 183,000.00
Mar 31, 2025 362.04 Mn
Dec 31, 2024 -3.98 Mn
Sep 30, 2024 3.20 Mn
Jun 30, 2024 4.22 Mn
Mar 31, 2024 1.34 Mn
Dec 31, 2023 5.42 Mn
Sep 30, 2023 741,000.00
Jun 30, 2023 183,000.00
Jun 30, 2022 183,000.00
Mar 31, 2022 183,000.00
Dec 31, 2021 183,000.00